• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东呼吸综合征3C样蛋白酶和严重急性呼吸综合征3C样蛋白酶催化机制的综合见解

Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease.

作者信息

Wang Hao, He Shuai, Deng Weilong, Zhang Ying, Li Guobang, Sun Jixue, Zhao Wei, Guo Yu, Yin Zheng, Li Dongmei, Shang Luqing

机构信息

State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and KLMDASR of Tianjin, Nankai University, No. 38 Tongyan Road, Haihe Education Park, Tianjin 300350, People's Republic of China.

Drug Discovery Center for Infectious Disease, Nankai University, 38 Tongyan Road, Haihe Education Park, Tianjin 300350, People's Republic of China.

出版信息

ACS Catal. 2020;10:5871-5890. doi: 10.1021/acscatal.0c00110. Epub 2020 Apr 28.

DOI:10.1021/acscatal.0c00110
PMID:32391184
Abstract

Coronavirus 3C-like protease (3CL) is a highly conserved cysteine protease employing a catalytic dyad for its functions. 3CL is essential to the viral life cycle and, therefore, is an attractive target for developing antiviral agents. However, the detailed catalytic mechanism of coronavirus 3CL remains largely unknown. We took an integrated approach of employing X-ray crystallography, mutational studies, enzyme kinetics study, and inhibitors to gain insights into the mechanism. Such experimental work is supplemented by computational studies, including the prereaction state analysis, the ab initio calculation of the critical catalytic step, and the molecular dynamic simulation of the wild-type and mutant enzymes. Taken together, such studies allowed us to identify a residue pair (Glu-His) and a conserved His as critical for binding; a conserved GSCGS motif as important for the start of catalysis, a partial negative charge cluster (PNCC) formed by Arg-Tyr-Asp as essential for catalysis, and a conserved water molecule mediating the remote interaction between PNCC and catalytic dyad. The data collected and our insights into the detailed mechanism have allowed us to achieve a good understanding of the difference in catalytic efficiency between 3CL from SARS and MERS, conduct mutational studies to improve the catalytic activity by 8-fold, optimize existing inhibitors to improve the potency by 4-fold, and identify a potential allosteric site for inhibitor design. All such results reinforce each other to support the overall catalytic mechanism proposed herein.

摘要

冠状病毒3C样蛋白酶(3CL)是一种高度保守的半胱氨酸蛋白酶,利用催化二元体发挥其功能。3CL对病毒生命周期至关重要,因此是开发抗病毒药物的一个有吸引力的靶点。然而,冠状病毒3CL的详细催化机制在很大程度上仍然未知。我们采用了X射线晶体学、突变研究、酶动力学研究和抑制剂等综合方法来深入了解其机制。此类实验工作由计算研究补充,包括预反应状态分析、关键催化步骤的从头计算以及野生型和突变型酶的分子动力学模拟。综合起来,这些研究使我们能够确定一对关键的结合残基(Glu-His)和一个保守的His;一个对催化起始很重要的保守GSCGS基序,一个由Arg-Tyr-Asp形成的部分负电荷簇(PNCC)对催化至关重要,以及一个介导PNCC与催化二元体之间远程相互作用的保守水分子。收集到的数据以及我们对详细机制的深入了解,使我们能够很好地理解SARS和MERS的3CL之间催化效率的差异,进行突变研究以将催化活性提高8倍,优化现有抑制剂以将效力提高4倍,并确定一个潜在的变构位点用于抑制剂设计。所有这些结果相互印证,支持本文提出的整体催化机制。

相似文献

1
Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease.中东呼吸综合征3C样蛋白酶和严重急性呼吸综合征3C样蛋白酶催化机制的综合见解
ACS Catal. 2020;10:5871-5890. doi: 10.1021/acscatal.0c00110. Epub 2020 Apr 28.
2
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS.配体诱导的中东呼吸综合征(MERS)冠状病毒nsp5蛋白酶(3CLpro)二聚化:对nsp5调控及抗病毒药物开发的启示
J Biol Chem. 2015 Aug 7;290(32):19403-22. doi: 10.1074/jbc.M115.651463. Epub 2015 Jun 8.
3
Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.基于与病毒蛋白酶分子相互作用的抗 SARS-CoV 药物的设计与评估。
Molecules. 2020 Aug 27;25(17):3920. doi: 10.3390/molecules25173920.
4
Mutational analysis of the active centre of coronavirus 3C-like proteases.冠状病毒3C样蛋白酶活性中心的突变分析。
J Gen Virol. 2002 Mar;83(Pt 3):581-593. doi: 10.1099/0022-1317-83-3-581.
5
Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors.严重急性呼吸综合征3C样蛋白酶的剖析研究揭示了额外结构域在该酶二聚化中的关键作用:将额外结构域定义为设计高特异性蛋白酶抑制剂的新靶点。
J Biol Chem. 2004 Jun 4;279(23):24765-73. doi: 10.1074/jbc.M311744200. Epub 2004 Mar 22.
6
Potential of coronavirus 3C-like protease inhibitors for the development of new anti-SARS-CoV-2 drugs: Insights from structures of protease and inhibitors.冠状病毒 3C 样蛋白酶抑制剂在开发新型抗 SARS-CoV-2 药物中的潜力:来自蛋白酶和抑制剂结构的见解。
Int J Antimicrob Agents. 2020 Aug;56(2):106055. doi: 10.1016/j.ijantimicag.2020.106055. Epub 2020 Jun 11.
7
Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL inhibitors.强效中东呼吸综合征冠状病毒(MERS-CoV)3CL蛋白酶抑制剂的鉴定与评估
Antiviral Res. 2017 May;141:101-106. doi: 10.1016/j.antiviral.2017.02.007. Epub 2017 Feb 17.
8
Characterization of Self-Processing Activities and Substrate Specificities of Porcine Torovirus 3C-Like Protease.猪传染性胃肠炎病毒 3C 样蛋白酶的自我加工活性和底物特异性的表征。
J Virol. 2020 Sep 29;94(20). doi: 10.1128/JVI.01282-20.
9
3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism.严重急性呼吸综合征冠状病毒的3C样蛋白酶通过一般碱机制催化底物水解。
Biochemistry. 2004 Apr 20;43(15):4568-74. doi: 10.1021/bi036022q.
10
Identification of novel proteolytically inactive mutations in coronavirus 3C-like protease using a combined approach.利用联合方法鉴定冠状病毒 3C 样蛋白酶的新型无蛋白水解活性突变。
FASEB J. 2019 Dec;33(12):14575-14587. doi: 10.1096/fj.201901624RR. Epub 2019 Nov 5.

引用本文的文献

1
Insights into the Activation of Unfolded Protein Response Mechanism during Coronavirus Infection.冠状病毒感染期间未折叠蛋白反应机制激活的见解
Curr Issues Mol Biol. 2024 May 5;46(5):4286-4308. doi: 10.3390/cimb46050261.
2
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.一种口服生物可利用的 SARS-CoV-2 主蛋白酶抑制剂,具有改善的亲和力和降低的突变敏感性。
Sci Transl Med. 2024 Mar 13;16(738):eadi0979. doi: 10.1126/scitranslmed.adi0979.
3
Reprogramming the Transition States to Enhance C-N Cleavage Efficiency of l-Amino Acid Oxidase.
重编程过渡态以提高L-氨基酸氧化酶的C-N裂解效率
JACS Au. 2024 Jan 16;4(2):557-569. doi: 10.1021/jacsau.3c00672. eCollection 2024 Feb 26.
4
Identification of a Putative SARS-CoV-2 Main Protease Inhibitor through In Silico Screening of Self-Designed Molecular Library.通过自行设计的分子文库的计算机筛选鉴定出一种潜在的 SARS-CoV-2 主要蛋白酶抑制剂。
Int J Mol Sci. 2023 Jul 13;24(14):11390. doi: 10.3390/ijms241411390.
5
Comprehensive Understanding of the Kinetic Behaviors of Main Protease from SARS-CoV-2 and SARS-CoV: New Data and Comparison to Published Parameters.全面了解 SARS-CoV-2 和 SARS-CoV 的主要蛋白酶的动力学行为:新数据与已发表参数的比较。
Molecules. 2023 Jun 7;28(12):4605. doi: 10.3390/molecules28124605.
6
Large library docking for novel SARS-CoV-2 main protease non-covalent and covalent inhibitors.大型文库对接新型 SARS-CoV-2 主蛋白酶非共价和共价抑制剂。
Protein Sci. 2023 Aug;32(8):e4712. doi: 10.1002/pro.4712.
7
Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches.使用多尺度计算方法揭示SARS-CoV-2木瓜样蛋白酶的催化机制以及C270突变的变构调节
Chem Sci. 2023 Apr 11;14(18):4681-4696. doi: 10.1039/d3sc00166k. eCollection 2023 May 10.
8
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.新型二硫代氨基甲酸盐选择性抑制 SARS-CoV-2 及其他冠状病毒的 3CL 蛋白酶。
Eur J Med Chem. 2023 Mar 15;250:115186. doi: 10.1016/j.ejmech.2023.115186. Epub 2023 Feb 6.
9
Prediction of Recurrent Mutations in SARS-CoV-2 Using Artificial Neural Networks.利用人工神经网络预测 SARS-CoV-2 的复发性突变。
Int J Mol Sci. 2022 Nov 24;23(23):14683. doi: 10.3390/ijms232314683.
10
Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics.基于计算机模拟的抗糖尿病药物西他列汀作为新型SARS-CoV-2抑制剂的评估:分子对接和分子动力学
3 Biotech. 2022 Dec;12(12):344. doi: 10.1007/s13205-022-03406-w. Epub 2022 Nov 7.